Response to: Ruxolitinib withdrawal due to the COVID-19

Saved in:
Bibliographic Details
Published inLeukemia Vol. 35; no. 4; p. 1219
Main Authors Barbui, Tiziano, Carobbio, Alessandra
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.04.2021
Nature Publishing Group
Subjects
692/308/174
692/699/1541/1990/2331
Cancer Research
Correspondence
COVID-19
Critical Care Medicine
Hematology
Humans
Intensive
Internal Medicine
Medicine
Medicine & Public Health
Neoplasms
Nitriles
Oncology
Pyrazoles - adverse effects
Pyrimidines
SARS-CoV-2
Online AccessGet full text

Cover

More Information
ISSN:0887-6924
1476-5551
DOI:10.1038/s41375-021-01187-4